These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24169116)

  • 1. License for destruction: tumor-specific cytokine targeting.
    Johansson A; Hamzah J; Ganss R
    Trends Mol Med; 2014 Jan; 20(1):16-24. PubMed ID: 24169116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications.
    De Bock K; Cauwenberghs S; Carmeliet P
    Curr Opin Genet Dev; 2011 Feb; 21(1):73-9. PubMed ID: 21106363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?
    Puré E; Lo A
    Cancer Immunol Res; 2016 Apr; 4(4):269-78. PubMed ID: 27036971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions that induce modifications in the tumor microenvironment.
    Bernhard EJ
    Cancer Radiother; 2011 Aug; 15(5):376-82. PubMed ID: 21571567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Intersection between Tumor Angiogenesis and Immune Suppression.
    Rahma OE; Hodi FS
    Clin Cancer Res; 2019 Sep; 25(18):5449-5457. PubMed ID: 30944124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond.
    Mittal K; Ebos J; Rini B
    Semin Oncol; 2014 Apr; 41(2):235-51. PubMed ID: 24787295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential applications of nanoparticles for tumor microenvironment remodeling to ameliorate cancer immunotherapy.
    Bai Y; Wang Y; Zhang X; Fu J; Xing X; Wang C; Gao L; Liu Y; Shi L
    Int J Pharm; 2019 Oct; 570():118636. PubMed ID: 31446027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of macrophage polarization in tumor angiogenesis and vessel normalization: implications for new anticancer therapies.
    Chen P; Bonaldo P
    Int Rev Cell Mol Biol; 2013; 301():1-35. PubMed ID: 23317816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine network: new targeted therapy for pancreatic cancer.
    Matsuo Y; Takeyama H; Guha S
    Curr Pharm Des; 2012; 18(17):2416-9. PubMed ID: 22372505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytokines in the epithelial cancer microenvironment.
    Wilson J; Balkwill F
    Semin Cancer Biol; 2002 Apr; 12(2):113-20. PubMed ID: 12027583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of mTOR Signaling in Tumor Microenvironment: An Overview.
    Conciatori F; Bazzichetto C; Falcone I; Pilotto S; Bria E; Cognetti F; Milella M; Ciuffreda L
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30126252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation in cancer.
    Hegmans JP; Aerts JG
    Curr Opin Pharmacol; 2014 Aug; 17():17-21. PubMed ID: 25011112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma.
    Chmielewski M; Hombach AA; Abken H
    Immunol Rev; 2014 Jan; 257(1):83-90. PubMed ID: 24329791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-Tumoral Inflammatory Myeloid Cells as Emerging Therapeutic Targets.
    Szebeni GJ; Vizler C; Nagy LI; Kitajka K; Puskas LG
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated macrophages as an emerging target against tumors: Creating a new path from bench to bedside.
    Jinushi M; Komohara Y
    Biochim Biophys Acta; 2015 Apr; 1855(2):123-30. PubMed ID: 25595840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor microenvironment: Interactions and therapy.
    Najafi M; Goradel NH; Farhood B; Salehi E; Solhjoo S; Toolee H; Kharazinejad E; Mortezaee K
    J Cell Physiol; 2019 May; 234(5):5700-5721. PubMed ID: 30378106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Vasculatures: A New Target for Cancer Immunotherapy.
    Liu Z; Wang Y; Huang Y; Kim BYS; Shan H; Wu D; Jiang W
    Trends Pharmacol Sci; 2019 Sep; 40(9):613-623. PubMed ID: 31331639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-mediated effects on angiogenesis in solid tumors.
    Martens B; Drebert Z
    J Steroid Biochem Mol Biol; 2019 Apr; 188():147-155. PubMed ID: 30654109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cytokines to tumors to induce active antitumor immune responses by recombinant fusion proteins.
    Xiang J
    Hum Antibodies; 1999; 9(1):23-36. PubMed ID: 10331183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.